NantHealth, Inc. (NASDAQ: NH) is a healthcare technology company focused on delivering precision medicine and data-driven solutions to healthcare providers, payers and pharmaceutical organizations. The company develops and markets integrated software platforms and molecular diagnostics designed to enable personalized treatment plans, improve patient outcomes and streamline clinical workflows. NantHealth’s core offerings include cloud-based clinical decision support systems, genomic sequencing services and real-time data analytics tools that combine clinical, molecular and imaging data.
Founded in 2007 by entrepreneur and physician Dr. Patrick Soon-Shiong, NantHealth has built a suite of products that leverage artificial intelligence and machine learning algorithms. Its flagship Clarify® Data Platform aggregates and normalizes diverse data types, while the GPS Cancer® program provides comprehensive genomic profiling to guide oncologists in selecting targeted therapies. The company also offers IoT-enabled digital health devices for remote monitoring and medication adherence, alongside telehealth solutions that facilitate virtual consultations and collaboration among multidisciplinary care teams.
Headquartered in Culver City, California, NantHealth operates laboratories and support centers in the United States and maintains strategic partnerships in Europe and the Asia-Pacific region. Its services are utilized by academic medical centers, community hospitals, specialty clinics and pharmaceutical firms seeking biomarker discovery, clinical trial enrichment and real-world evidence generation. By integrating precision diagnostics with cloud-based workflows, NantHealth aims to reduce variability in care delivery and accelerate research into novel therapies.
Under the leadership of founder and Executive Chairman Dr. Patrick Soon-Shiong and an experienced executive management team, NantHealth continues to expand its product portfolio and global footprint. The company invests in ongoing research and development to enhance its AI-driven analytics, refine its sequencing assays and extend its digital health capabilities. NantHealth’s mission is to transform healthcare through the convergence of cutting-edge technology, molecular science and real-world clinical data.
AI Generated. May Contain Errors.
Free NH Stock Alerts